Parameter | First collection (October) ( |
Second collection (April) ( |
---|---|---|
RBC (1012/L) | 10.52 ± 1.80 | 11.53 ± 1.92 |
HGB (g/L) | 16.19 ± 2.11a | 17.77 ± 2.63a |
HCT (L/L) | 0.43 ± 0.05a | 0.54 ± 0.08a |
MCV (fL) | 41.72 ± 4.98a | 47.00 ± 4.10a |
MCH (pg) | 15.56 ± 1.45 | 15.50 ± 1.22 |
MCHC (g/dL) | 37.52 ± 1.30a | 33.25 ± 0.80a |
WBC (109/L) | 6.20 ± 1.80 | 5.35 ± 1.74 |
LYM (109/L) | 3.50 ± 1.04 | 3.11 ± 1.17 |
MID (109/L) | 0.41 ± 0.28 | 0.42 ± 0.20 |
GRA (109/L) | 2.30 ± 1.07 | 1.82 ± 1.12 |
PLT (109/L) | 211.07 ± 69.69 | 212.57 ± 85.40 |
MPV (fL) | 6.01 ± 0.52 | 5.90 ± 0.36 |
Total protein (g/L) | 66.00 ± 4.44a | 73.07 ± 8.96a |
Albumin (g/L) | 37.17 ± 3.72 | 39.47 ± 8.49 |
Cholesterol (mmol/L) | 1.82 ± 0.34 | 1.83 ± 0.31 |
HDL (mmol/L) | 1.25 ± 0.23 | 1.20 ± 0.22 |
LDL (mmol/L) | 0.62 ± 0.19a | 0.47 ± 0.20a |
Triglyceride (mmol/L) | 0.20 ± 0.11a | 0.15 ± 0.08a |
First collection | Second collection | |
---|---|---|
Parameter | (October) | (April) |
( |
( |
|
Serum | ||
SOD (U/mL) | 21.96 ± 6.70 | 20.01 ± 5.62 |
CAT (U/mL) | 50.33 ± 19.23a | 27.53 ± 15.15a |
GR (U/L) | 160.58 ± 82.74a | 224.29 ± 71.94a |
PON(U/mL) 1 (paraoxonase) | 239.60 ± 62.19 | 242.63 ± 61.96 |
PON(U/mL) 1 (arylesterase) | 171.57 ± 36.25 | 186.53 ± 52.90 |
PON(U/mmoL) 1/HDL ratio | 207.27 ± 65.30 | 200.13 ± 61.16 |
TAS (mmol/L) | 0.71 ± 0.25 | 0.79 ± 0.14 |
total (μmol/bilirubin L) | 5.99 ± 3.25 | 6.70 ± 3.11 |
uric acid (mmol/L) | 0.02 ± 0.01 | 0.02 ± 0.03 |
Haemolysate | ||
SOD (U/mL) | 256.34 ± 66.44 | 292.27 ± 107.24 |
SOD (U/g Hb) | 1608.82 ± 462.90 | 1676.88 ± 611.50 |
total (μmol/glutathione L) | 71.16 ± 30.67a | 94.91 ± 39.89a |
GSSG (μmol/L) | 59.31 ± 23.64a | 73.96 ± 30.37a |
Plasma/serum | ||
MDA in plasma | 1.38 ± 0.35a | 1.19 ± 0.31a |
BHB in serum (mmol/L) | 0.26 ± 0.07a | 0.43 ± 0.12a |